Amivantamab (Anti-cMet & EGFR)
Product Specifications
CAS Number
2171511-58-1
Synonyms
JNJ-61186372
Target
EGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Amivantamab is a fully human bispecific antibody that targets both epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition factor (MET) . It exhibits immune anticancer activity in non-small cell lung cancer (NSCLC) . MW :145.88 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042429-500 1x 500 µL
CD44v3 (Marker of Tumor Metastasis) (3G5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
